CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast...
Phase 1
Nashville, Tennessee, United States and 5 other locations
This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...
Phase 2
Nashville, Tennessee, United States and 5 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Nashville, Tennessee, United States and 8 other locations
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...
Phase 3
Nashville, Tennessee, United States and 70 other locations
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Nashville, Tennessee, United States and 23 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Nashville, Tennessee, United States and 11 other locations
This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...
Phase 1
Nashville, Tennessee, United States and 17 other locations
the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple...
Phase 3
Nashville, Tennessee, United States and 137 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Nashville, Tennessee, United States and 506 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Nashville, Tennessee, United States and 508 other locations
Clinical trials
Research sites
Resources
Legal